Idex's Corporate Customers have recorded an advance in their cost of revenue by 6.88 % in the 2 quarter 2026 year on year, sequentially costs of revenue grew by 3.71 %. During the corresponding time, Idex Corp recorded a revenue increase by 6.38 % year on year, sequentially revenue grew by 3.8 %. While revenue at the Idex Corp's corporate clients recorded rose by 22.7 % year on year, sequentially revenue grew by 19.12 %.
Idex's Customers have recorded an advance in their cost of revenue by 6.88 % in the 2 quarter 2026 year on year, sequentially costs of revenue grew by 3.71 %, for the same period Idex Corp recorded revenue increase by 6.38 % year on year, sequentially revenue grew by 3.8 %.
IDEX operates through three reportable segments: Health & Science Technologies (HST), Fluid & Metering Technologies (FMT), and Fire & Safety/Diversified Products (FSDP). The HST segment offers precision fluidics, pumps, powder and liquid processing technologies, drying systems, micro-precision components, pneumatic components, sealing solutions, medical devices, optical components, diamond tools, laboratory equipment, photonic solutions, technical ceramics, and flow control solutions. Its end markets include Life Sciences—comprising analytical instruments, pharmaceutical, and medical/dental markets from 2025 onward—Agriculture, Energy, and others. The segments are organized to align with customer needs based on product and market similarities as well as shared distribution and production methods. In 2025, sales were distributed as 43% HST, 35% FMT, and 22% FSDP. IDEX focuses on organic growth, strategic acquisitions, and capital allocation to support its market operations.
IDEX Corporation Unveils $1 Billion Share Repurchase Capacity Amid Revenue BoostIn a significant move to bolster shareholder value, IDEX Corporation (NYSE:IEX), a renowned player in the industrial technology sector, has announced an expansion of its share repurchase authorization, elevating the total buyback capacity to an impressive $1 billion. This decision reflects IDEX s commitment to enhancing shareholder returns while maintaining robust financial health. Concurrently, the corporation declared its regular quarterly cash dividend, underscoring its dedication to delivering consistent value to its investors.This strategic financial maneuver coincides with IDEX Corporation s notable financial performance i...
Idex’s Comment on Sales, Marketing and Customers
IDEX operates through three reportable segments: Health & Science Technologies (HST), Fluid & Metering Technologies (FMT), and Fire & Safety/Diversified Products (FSDP). The HST segment offers precision fluidics, pumps, powder and liquid processing technologies, drying systems, micro-precision components, pneumatic components, sealing solutions, medical devices, optical components, diamond tools, laboratory equipment, photonic solutions, technical ceramics, and flow control solutions. Its end markets include Life Sciences—comprising analytical instruments, pharmaceutical, and medical/dental markets from 2025 onward—Agriculture, Energy, and others. The segments are organized to align with customer needs based on product and market similarities as well as shared distribution and production methods. In 2025, sales were distributed as 43% HST, 35% FMT, and 22% FSDP. IDEX focuses on organic growth, strategic acquisitions, and capital allocation to support its market operations.
Sources:
Idex Corp’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Idex Corp’s corporate clients.
For your research, we’ve provided 9 tables on Idex Corp corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
44.81 %
12.27 % 